DDA has been implementing the WHO guidelines on stability testing in phased manner.
Cooperation of the industry and progress made in implementing the stability requirement is praiseworthy. All manufacturers are requested to adopt the WHO working document QAS/06.179/Rev.1 on “Stability testing of active pharmaceutical ingredients and pharmaceutical products, 2007″ as far as possible. However the following is the minimum requirement that has to be complied for applying for marketing authorization of the product on or after Shrawan 1, 2064.